IRCCS Mondino Foundation
Published August 5, 2021 | Version v1
Dataset Restricted

20210804_erenumab_Headache_SB_01

Authors/Creators

  • 1. IRCCS Mondino Foundation, Pavia (Italy)
  • 2. IRCCS Mondino Foundation, Pavia ; University of Pavia (Italy)

Description

Dataset refers to the evaluation of psychological predictors of the outcome of 12-month of treatment with Erenumab in Chronic Migraine patients: Responders (reduction ≥ 50% in migraine days) vs Non Responders (reduction < 50% in migraine days). To this end, patients at baseline received a full psychological evaluation using The Structured Clinical Interview for DSM-5 Clinician Version (SCID-5-CV) to assess mood, anxiety, and personality disorders as well specific questionnaires to evaluate alexithymia traits, childhood traumas, and current life-event stressors. Results highlighted that the presence of current stressors, anxiety and Cluster C personality disorders represent negative predictors of treatment outcome.

Notes

Funding: Ricerca Corrente 2017-2019, Ministry of Health (Italy)

Files

Restricted

The record is publicly accessible, but files are restricted. Log in to check if you have access.

Request access

If you would like to request access to these files, please fill out the form below.

You need to satisfy these conditions in order for this request to be accepted:

This data set of raw data is accessible under request by writing to the Scientific Direction of the IRCCS Mondino Foundation (dirsci@mondino.it) specifying:

  1. own affiliation;
  2. how one intends to use data.

You are currently not logged in. Do you have an account? Log in here